跳至主要内容
临床试验/JPRN-UMIN000016500
JPRN-UMIN000016500已完成未知

Safety and efficacy of live attenuated vaccine in patients received hematopoietic stem cell transplantation - FBMTG-VAC2015

Fukkuoka Blood and Marrow Transplantation Group0 个研究点目标入组 300 人开始时间: 2015年2月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patient who received immunosuppressive medications. 2. History of malignant tumors. 3. Severe uncontrolled psychiatric disorder or illness. 4. Serious concurrent uncontrolled medical disorders (hepatic dysfunction, renal failure, cardiac dysfunction, pulmonary dysfunction, diabetes, hypertension and infectious diseases). 5. Pregnant or lactating female. 6. Unwillingness or inability to follow the procedures required in the protocol.

研究者

发起方
Fukkuoka Blood and Marrow Transplantation Group

相似试验